The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma

Hye Jeong Park(Jeonbuk National University Hospital), Kyu Yun Jang(Jeonbuk National University Hospital)
Journal of Experimental & Clinical Cancer Research
May 21, 2018
Cited by 96


Related Papers